# lamivudine

NDC: 62135-706
Generic name: lamivudine oral
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20141031

FDA application: ANDA203564

## Active ingredients

- LAMIVUDINE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-706"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-706
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef9977cb-ec91-46d7-b769-d26decfd6fe7